Company intelligence / Profile preview

Genting

Ownership: Private
Employees: ~54000
Development stage: Other

Overview

Genting is a major Malaysian conglomerate with a significant presence in leisure/hospitality but also an active investor/operator in life sciences. Its biotech division includes strategic stakes or partnerships with innovative biotech firms such as Celularity Inc. (cell therapies), TauRx Pharmaceuticals Ltd. (Alzheimer’s drugs), Synthetic Genomics Vaccines Inc., DNA Electronics Ltd., among others. Clinical results from portfolio companies include promising late-stage data on Alzheimer’s treatment and ongoing trials of novel cell therapies for cancer/COVID.

Therapeutic areas: OncologyNeurologyInfectious Diseases
Modalities: Cell therapySmall moleculeGenomic technologiesSynthetic genomicsDiagnostic devices
Industry: Investors

Partnerships

Strategic partnership with Celularity Inc.—joint development/commercialization of stem cell therapeutics across Asia-Pacific including new Bali facility Fontaine VitaleJoint venture with TauRx Pharmaceuticals—focus on redefining healthcare delivery for Alzheimer’s/cognitive impairment across Asia

Beyond the preview

Go deeper on Genting.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Genting.

Explore the full profile